Human immunodeficiency virus neutralizing antibodies
US10239935B2 · kind B2 · utility
2Cited by
6References
71Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2016 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Dec 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.